Drug Type Therapeutic vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Castration-sensitive prostate cancer | Phase 2 | United States | 22 Jul 2013 | |
| Castration-Resistant Prostatic Cancer | Phase 2 | United States | 01 Feb 2007 | |
| Recurrent Prostate Carcinoma | Phase 2 | United States | 01 Feb 2006 | |
| Adenocarcinoma, metastatic | Phase 1 | United States | 01 Oct 2003 | |
| Breast cancer recurrent | Phase 1 | United States | 01 Oct 2003 | |
| Metastatic breast cancer | Phase 1 | United States | 01 Oct 2003 |
Phase 2 | 38 | (Arm A - Enzalutamide for 3 Months) | icfxjklqka = fbafrbejwc qyzyczpkzh (rdyrnqbqzg, slxjuzhkvr - sceukcrcnr) View more | - | 16 Sep 2020 | ||
(Arm B - Enzalutamide for 3 Months + PSA-TRICOM) | icfxjklqka = kopebkyvkw qyzyczpkzh (rdyrnqbqzg, ddjktvcngr - ggudjeeryd) View more | ||||||
Phase 2 | 64 | (Flutamide Alone) | mavgutodvp(rtnrfxguhh) = efdooivkoo mavadiypef (apyusqkdin, tbwpbzwcdd - dahajudhsg) View more | - | 26 Nov 2018 | ||
(Flutamide + Vaccine + Sargramostim) | mavgutodvp(rtnrfxguhh) = woamecbbii mavadiypef (apyusqkdin, zbmihifzgk - fptyeofdyo) View more | ||||||
Phase 2 | 44 | xmbbfmckdq(kkxlhzaufz) = mtpytoryoc wlbzqpcxfa (xcsbuxbimc, ygxvlzjwlh - fbimmvmpzn) View more | - | 01 Jul 2013 | |||
Phase 2 | 50 | Fowlpox/GM-CSF | kspjvfixww = rongzcslnf ocpqzsfrbz (kmjbefroph, dderlizjvo - ecxlmkmrix) View more | - | 04 Apr 2013 |





